These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Modeling, identification and parameter estimation of bilirubin kinetics in normal, hemolytic and Gilbert's states. Cobelli C; Frezza M; Tiribelli C Comput Biomed Res; 1975 Dec; 8(6):522-37. PubMed ID: 1212845 [No Abstract] [Full Text] [Related]
24. Hereditary hyperbilirubinemias. Odell GB; Childs B Prog Med Genet; 1980; 4():103-34. PubMed ID: 7003652 [No Abstract] [Full Text] [Related]
25. An expanded model of bilirubin kinetics: effect of feeding, fasting, and phenobarbital in Gilbert's syndrome. Kirshenbaum G; Shames DM; Schmid R J Pharmacokinet Biopharm; 1976 Apr; 4(2):115-55. PubMed ID: 950587 [No Abstract] [Full Text] [Related]
26. [Clinical, biochemical and morphologic analysis of congenital non-hemolytic hyperbilirubinemia]. Czarnecki J; Cichoz H; Słomka M; Siezieniewska Z; Czechowska G Wiad Lek; 1988 Sep; 41(17):1151-6. PubMed ID: 3242266 [No Abstract] [Full Text] [Related]
28. [Usefulness of the determination of bile acids in the blood and antipyrine elimination in the diagnosis of minimal liver damage]. Habior A Przegl Lek; 1983; 40(5):431-4. PubMed ID: 6622742 [No Abstract] [Full Text] [Related]
29. [Kinetic study of unconjugated bilirubin before and after phenobarbital treatment of 10 patients with Gilbert's syndrome]. Vincenzi M; Betti R Minerva Dietol Gastroenterol; 1984; 30(1):31-5. PubMed ID: 6728222 [No Abstract] [Full Text] [Related]
30. [Pharmacokinetics of tribuzone (Benetazone Spofa) in patients with Gilbert's syndrome (author's transl)]. Petera V; Mayer O; Cepelák V Cesk Gastroenterol Vyz; 1980 Oct; 34(7):447-50. PubMed ID: 7192607 [No Abstract] [Full Text] [Related]
32. Gilbert's syndrome--clinical and pharmacological implications. Radu P; Atsmon J Isr Med Assoc J; 2001 Aug; 3(8):593-8. PubMed ID: 11519385 [No Abstract] [Full Text] [Related]
33. Glucuronidation of bilirubin and the occurrence of pigment gallstones in patients with chronic haemolytic diseases. Fevery J; Verwilghen R; Tan TG; De Groote J Eur J Clin Invest; 1980 Jun; 10(3):219-26. PubMed ID: 6783418 [TBL] [Abstract][Full Text] [Related]
34. [Comparative studies on defective indocyanine green excretion by the liver in patients with and without Gilbert's disease (author's transl)]. Okubo H; Musha H; Kotada K; Okuda K Nihon Shokakibyo Gakkai Zasshi; 1975 Aug; 72(8):992-1001. PubMed ID: 1238758 [No Abstract] [Full Text] [Related]
35. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Kadakol A; Ghosh SS; Sappal BS; Sharma G; Chowdhury JR; Chowdhury NR Hum Mutat; 2000 Oct; 16(4):297-306. PubMed ID: 11013440 [TBL] [Abstract][Full Text] [Related]
37. Animal model of human disease. Increased sensitivity to polychlorinated biphenyls. Animal model: gunn rats with hereditary hyperbilirubinemia. Calabrese EJ Am J Pathol; 1978 May; 91(2):405-8. PubMed ID: 417632 [No Abstract] [Full Text] [Related]
38. Increased glucuronidation of bilirubin in man and rat by administration of antipyrine (phenazone). Orme ML; Davies L; Breckenridge A Clin Sci Mol Med; 1974 Apr; 46(4):511-8. PubMed ID: 4208404 [No Abstract] [Full Text] [Related]
39. [Hepatic disorders of bilirubin metabolism of the Gilbert type]. Misiewicz A; Braczkowski R; Trzcionka-Chomko D Pol Tyg Lek; 1983 Aug; 38(31):971-2. PubMed ID: 6664917 [No Abstract] [Full Text] [Related]